scholarly article | Q13442814 |
P356 | DOI | 10.3109/10428199509049773 |
P698 | PubMed publication ID | 7719240 |
P50 | author | Francesco Buccisano | Q41237865 |
Adriano Venditti | Q41237877 | ||
Giovanni Del Poeta | Q56950902 | ||
Sandro Grelli | Q59243018 | ||
P2093 | author name string | A Mastino | |
G Papa | |||
C Favalli | |||
E Garaci | |||
R Stasi | |||
M T Scimò | |||
P2860 | cites work | Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia | Q28266438 |
Proposals for the classification of the myelodysplastic syndromes | Q28275931 | ||
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines | Q30502375 | ||
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia | Q33457422 | ||
Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system | Q34248639 | ||
Human preleukaemia: do we have a model? | Q36027591 | ||
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity | Q39337365 | ||
The 5q-anomaly | Q39822203 | ||
Abolished Production of Interferon by Leucocytcs of Patients with the Acquired Cytogcnetic Abnormalities 5q — or — 5 in Secondary and de-Novo Acute Non-lymphocytic Leukaemia | Q40858957 | ||
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia | Q41862826 | ||
Enhanced NK cell activity in mice injected with interferon and interferon inducers | Q41935188 | ||
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice | Q44980347 | ||
All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case report | Q46034774 | ||
A common progenitor for human myeloid and lymphoid cells | Q59048641 | ||
P433 | issue | 3-4 | |
P921 | main subject | cytarabine | Q180983 |
P304 | page(s) | 335-342 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study | |
P478 | volume | 16 |